Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Long Term Exposure to Myrtucommulone-A Changes CD105 Expression and Differentiation Potential of Mesenchymal Stem Cells

Izgi K., Sonmez M. F., CANATAN H., Iskender B.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE , cilt.14, sa.2, ss.113-121, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Current status in cancer cell reprogramming and its clinical implications

Izgi K., CANATAN H., Iskender B.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.143, sa.3, ss.371-383, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A

Izgia K., Iskender B., Sakalar C., Arslanhan A., Yuksek E. H., Hizar E., et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.17, sa.3, ss.404-414, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Reprogramming bladder cancer cells for studying cancer initiation and progression

Iskender B., Izgi K., CANATAN H.
TUMOR BIOLOGY , cilt.37, sa.10, ss.13237-13245, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Integrin-Associated Focal Adhesion Kinase Protects Human Embryonic Stem Cells from Apoptosis, Detachment, and Differentiation

Vitillo L., Baxter M., Iskender B., Whiting P., Kimber S. J.
STEM CELL REPORTS , cilt.7, sa.2, ss.167-176, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling

Iskender B., Izgi K., Hizar E., Jauch J., Arslanhan A., Yuksek E. H., et al.
TUMOR BIOLOGY , cilt.37, sa.6, ss.8281-8291, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis

Iskender B., Izgi K., CANATAN H.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.416, sa.1-2, ss.71-84, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer

Sakalar C., Izgi K., Iskender B., Sezen S., Aksu H., Cakir M., et al.
TUMOR BIOLOGY , cilt.37, sa.4, ss.4467-4477, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?

Iskender B., Izgi K., Sakalar C., CANATAN H.
TUMOR BIOLOGY , cilt.37, sa.2, ss.1967-1981, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9

Iskender B., Izgi K., Karaca H., CANATAN H.
JOURNAL OF NATURAL MEDICINES , cilt.69, sa.4, ss.543-554, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Myrtucommulone-A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells

Izgi K., Iskender B., Jauch J., Sezen S., Cakir M., Charpentier M., et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , cilt.29, sa.9, ss.432-439, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice

Izgi K., Iskender B., Sakalar C., Arslanhan A., SARAYMEN B., CANATAN H.
EUROPEAN CYTOKINE NETWORK , cilt.26, sa.2, ss.46-56, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell Maintenance

Soteriou D., Iskender B., Byron A., Humphries J. D., Borg-Bartolo S., Haddock M., et al.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.288, sa.26, ss.18716-18731, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

Human feeder cell line for derivation and culture of hESc/hiPSc

McKay T. R., Camarasa M. V., Iskender B., Ye J., Bates N., Miller D., et al.
STEM CELL RESEARCH , cilt.7, sa.2, ss.154-162, 2011 (SCI-Expanded) identifier identifier identifier
Diğer Dergilerde Yayınlanan Makaleler

The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling Aktif Bileşen Timokinon İnsan Mezenkimal Kök Hücrelerinin Kondrojenik Farklılaşmasını Hücre İçi Sinyal Mekanizmaları Aracılığıyla Değiştirir

Iskender B.
Medeniyet Medical Journal , cilt.37, sa.1, ss.1-12, 2022 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

İnsan embriyonik kök hücreleri ve mikroçevre

İskender B., İzgi K., Şanlıoğlu S., Canatan H.
Journal of Clinical and Experimental Investigations , cilt.5, sa.3, ss.486-495, 2014 (Hakemli Dergi) identifier

İndüklenmiş pluripotent kök hücreler ve hücre tedavisi

İskender B., Canatan H.
Journal of Clinical and Experimental Investigations , cilt.4, sa.4, ss.550-561, 2013 (Hakemli Dergi) identifier
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Alterations in tumorigenicity and immunogenicity of bladder cancer cells after somatic cell reprogramming

İskender İzgi B., Barlak B. S. R., Kongur Z. S., Sarıhan M., Akpınar G., Kasap M.
ESMO Immuno-Oncology Congress, Geneve, İsviçre, 11 - 13 Aralık 2024, ss.0-1

Distinctive protein expression patterns in reprogrammed and ancestral bladder cancer cells

İskender İzgi B., Barlak B. S. R., Sarıhan M., Kongur Z. S., Akpınar G., Kasap M.
International Proteomics Congress 6th Turkish National Proteomics Congress, Kocaeli, Türkiye, 11 - 12 Ekim 2024, ss.28

Reprogramming-induced changes in protein content of bladder cancer cell line UM-UC-3.

Barlak B. S. R., Sarıhan M., Kongur Z. S., Akpınar G., Kasap M., İskender İzgi B.
TuPA International Proteomics Congress 6th Turkish National Proteomics Congress, Kocaeli, Türkiye, 11 - 12 Ekim 2024, ss.34

Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells

Barlak B. S. R., İskender İzgi B.
EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities, Bergamo, İtalya, 19 - 21 Mart 2024

Prospects for cell reprogramming in cancer remodelling and treatment: A special emphasis on bladder cancer.

İskender İzgi B.
2nd International Multidisciplinary Cancer Research Congress, Giresun, Türkiye, 21 - 24 Temmuz 2022, cilt.1, ss.2-3

Generation of Virus Integration-Free and Feeder-Free Induced Pluripotent Stem Cells from Human CD34+ Blood Cells

İskender İzgi B.
8th International Medicine and Health Sciences Researches Congress, Ankara, Türkiye, 25 Aralık 2021, ss.250-251

Combination Treatment Potentiates the Effects of Anticancer Drugs by Targeting Epithelial-Mesenchymal Transition-related Factors

İskender İzgi B.
3rd International Congress on Medical Sciences and Multidisciplinary Approaches, İstanbul, Türkiye, 2 - 03 Aralık 2021, ss.404
Metrikler

Yayın

24

Atıf (WoS)

333

H-İndeks (WoS)

11

Atıf (Scopus)

354

H-İndeks (Scopus)

11

Atıf (Scholar)

395

H-İndeks (Scholar)

10

Atıf (TrDizin)

5

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

5

Proje

11

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları